Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 202

Similar articles for PubMed (Select 8792761)

1.

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis.

Aronson R, Offman HJ, Joffe RT, Naylor CD.

Arch Gen Psychiatry. 1996 Sep;53(9):842-8.

PMID:
8792761
2.
3.
5.

Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature.

Altshuler LL, Bauer M, Frye MA, Gitlin MJ, Mintz J, Szuba MP, Leight KL, Whybrow PC.

Am J Psychiatry. 2001 Oct;158(10):1617-22.

PMID:
11578993
6.

[Combination therapies in antidepressive drug refractory depression--an overview].

Schmauss M, Erfurth A.

Fortschr Neurol Psychiatr. 1996 Oct;64(10):390-402. Review. German.

PMID:
9036099
8.

Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.

Kasper S.

Int Clin Psychopharmacol. 1995 Dec;10 Suppl 4:25-35. Review. Erratum in: Int Clin Psychopharmacol 1996 Jun;11(2):153.

PMID:
8930007
9.

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.

Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.

Arch Gen Psychiatry. 2007 Jun;64(6):679-88.

PMID:
17548749
10.

Efficacy of newer medications for treating depression in primary care patients.

Mulrow CD, Williams JW Jr, Chiquette E, Aguilar C, Hitchcock-Noel P, Lee S, Cornell J, Stamm K.

Am J Med. 2000 Jan;108(1):54-64. Review.

PMID:
11059441
11.

Treatment of depression--newer pharmacotherapies.

Mulrow CD, Williams JW Jr, Trivedi M, Chiquette E, Aguilar C, Cornell JE, Badgett R, Noël PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS, Stamm K.

Psychopharmacol Bull. 1998;34(4):409-795. Review.

PMID:
10513454
12.
13.

Antidepressant therapy for unexplained symptoms and symptom syndromes.

O'Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K.

J Fam Pract. 1999 Dec;48(12):980-90. Review.

PMID:
10628579
14.

What role do atypical antipsychotic drugs have in treatment-resistant depression?

Thase ME.

J Clin Psychiatry. 2002 Feb;63(2):95-103. Review.

PMID:
11874227
15.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.

Mol Psychiatry. 2006 Jul;11(7):622-32. Epub 2006 Apr 4. Review. Erratum in: Mol Psychiatry. 2006 Aug;11(8):795.

PMID:
16585942
16.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
17.

Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies.

Papakostas GI, Cooper-Kazaz R, Appelhof BC, Posternak MA, Johnson DP, Klibanski A, Lerer B, Fava M.

Int Clin Psychopharmacol. 2009 Jan;24(1):19-25. doi: 10.1097/YIC.0b013e328314dfaf. Review.

PMID:
19092448
18.

Lithium augmentation of antidepressants in treatment-refractory depression.

Heit S, Nemeroff CB.

J Clin Psychiatry. 1998;59 Suppl 6:28-33; discussion 34. Review.

PMID:
9674934
19.

Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.

Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z.

Arch Gen Psychiatry. 2006 Nov;63(11):1217-23. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk